|
| |
Diabetes: Cause And Prevention
An individual may get diabetes when the pancreas can no longer secrete the needed hormones that produce insulin. The insulin maintains the glucose in the blood to be normal. Low insulin means that the level of glucose, which is sugar in the blood, may get ...
Gout: A Foe for your Toe
Gout: A Foe for your ToeGout is a misunderstood malady. Despite the intense pain that gout can bring, it is a condition that is rarely makes the glossy pages of a magazine. If you are ever personally hit with the sudden onset of gout, classically (50% of ...
Pain in the butt. How to deal with hemorrhoids?
Pain in the butt. How to deal with hemorrhoids?This is very sensitive area of your body. Too private. Nobody likes when something is wrong over there. However it happens.Hemorrhoids occur practically in everyone. Though hemorrhoids cause problems in 1 out ...
|
|
|
| |
Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos - far short of achieving statistical significance.
Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.
The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.
Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.
The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.
Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.
Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.
About the author:
Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution pr
|
|
|
|
|
|
|
|
 Bad Beltway Medicine - CBS News
Questions and answers regarding various aspects of the current economic crisis. They say that those who don’t learn from history are destined to repeat it. As we’re being greeted almost daily with a new bailout proposal - with one forthcoming ...
'Alternative' Medicine Is Mainstream - Wall Street Journal
In mid-February, the Institute of Medicine of the National Academy of Sciences and the Bravewell Collaborative are convening a "Summit on Integrative Medicine and the Health of the Public." This is a watershed in the evolution of integrative medicine ...
Edward J. Ill Excellence in Medicine Foundation Announces 2009 ... - PR.com
Lawrenceville, NJ, January 09, 2009 --( PR.com )-- Carrying forward a seventy year tradition of recognizing exceptional physicians and leaders in healthcare, the Edward J. Ill Excellence in Medicine Foundation today announced the 2009 honorees for ...
Kenneth G. Swan, MD, Recognized for “Excellence In Medicine” - PR.com
Lawrenceville, NJ, January 09, 2009 --( PR.com )-- Paul J. Hirsch, MD, Chairman of the Edward J. Ill Excellence in Medicine Foundation, today announced that Kenneth G. Swan, MD, will receive the Edward J. Ill Physician’s Award®. The award will be ...
Don't have a cow, but FDA could approve goat-made medicine - Scientific American
Some consumer groups are bleating over the prospect of a new anti-clotting drug made from genetically modified goats. An advisory committee to the Food and Drug Administration (FDA) is meeting today to discuss whether to recommend approval of ATryn ...
|
